nodes	percent_of_prediction	percent_of_DWPC	metapath
Fentanyl—CYP3A7—Sorafenib—liver cancer	0.133	0.25	CbGbCtD
Fentanyl—CYP3A7-CYP3A51P—Sorafenib—liver cancer	0.133	0.25	CbGbCtD
Fentanyl—CYP3A5—Sorafenib—liver cancer	0.0997	0.187	CbGbCtD
Fentanyl—ABCB1—Sorafenib—liver cancer	0.0649	0.122	CbGbCtD
Fentanyl—ABCB1—Doxorubicin—liver cancer	0.0394	0.074	CbGbCtD
Fentanyl—CYP3A4—Sorafenib—liver cancer	0.0389	0.073	CbGbCtD
Fentanyl—CYP3A4—Doxorubicin—liver cancer	0.0236	0.0443	CbGbCtD
Fentanyl—Influenza—Epirubicin—liver cancer	0.000373	0.000924	CcSEcCtD
Fentanyl—Dysphagia—Epirubicin—liver cancer	0.000373	0.000924	CcSEcCtD
Fentanyl—Dehydration—Doxorubicin—liver cancer	0.000372	0.00092	CcSEcCtD
Fentanyl—Vomiting—Sorafenib—liver cancer	0.000365	0.000904	CcSEcCtD
Fentanyl—Orthostatic hypotension—Doxorubicin—liver cancer	0.000365	0.000903	CcSEcCtD
Fentanyl—Abdominal pain upper—Doxorubicin—liver cancer	0.000365	0.000903	CcSEcCtD
Fentanyl—Hypokalaemia—Doxorubicin—liver cancer	0.000364	0.0009	CcSEcCtD
Fentanyl—Angina pectoris—Epirubicin—liver cancer	0.000364	0.0009	CcSEcCtD
Fentanyl—Benazepril—MTHFR—liver cancer	0.000363	0.664	CrCbGaD
Fentanyl—Rash—Sorafenib—liver cancer	0.000362	0.000896	CcSEcCtD
Fentanyl—Dermatitis—Sorafenib—liver cancer	0.000362	0.000895	CcSEcCtD
Fentanyl—Breast disorder—Doxorubicin—liver cancer	0.000361	0.000894	CcSEcCtD
Fentanyl—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00036	0.00089	CcSEcCtD
Fentanyl—Headache—Sorafenib—liver cancer	0.00036	0.00089	CcSEcCtD
Fentanyl—Bronchitis—Epirubicin—liver cancer	0.000359	0.000888	CcSEcCtD
Fentanyl—Nasopharyngitis—Doxorubicin—liver cancer	0.000358	0.000884	CcSEcCtD
Fentanyl—Pancytopenia—Epirubicin—liver cancer	0.000355	0.000877	CcSEcCtD
Fentanyl—Gastritis—Doxorubicin—liver cancer	0.000354	0.000875	CcSEcCtD
Fentanyl—Muscular weakness—Doxorubicin—liver cancer	0.000353	0.000872	CcSEcCtD
Fentanyl—Neutropenia—Epirubicin—liver cancer	0.000349	0.000864	CcSEcCtD
Fentanyl—Dysuria—Epirubicin—liver cancer	0.000349	0.000864	CcSEcCtD
Fentanyl—Abdominal distension—Doxorubicin—liver cancer	0.000348	0.00086	CcSEcCtD
Fentanyl—Upper respiratory tract infection—Epirubicin—liver cancer	0.000347	0.000858	CcSEcCtD
Fentanyl—Asthma—Doxorubicin—liver cancer	0.000346	0.000855	CcSEcCtD
Fentanyl—Dysphagia—Doxorubicin—liver cancer	0.000346	0.000855	CcSEcCtD
Fentanyl—Influenza—Doxorubicin—liver cancer	0.000346	0.000855	CcSEcCtD
Fentanyl—Pollakiuria—Epirubicin—liver cancer	0.000345	0.000853	CcSEcCtD
Fentanyl—Nausea—Sorafenib—liver cancer	0.000341	0.000844	CcSEcCtD
Fentanyl—Weight increased—Epirubicin—liver cancer	0.00034	0.000841	CcSEcCtD
Fentanyl—Weight decreased—Epirubicin—liver cancer	0.000338	0.000836	CcSEcCtD
Fentanyl—Hyperglycaemia—Epirubicin—liver cancer	0.000337	0.000833	CcSEcCtD
Fentanyl—Angina pectoris—Doxorubicin—liver cancer	0.000337	0.000833	CcSEcCtD
Fentanyl—Pneumonia—Epirubicin—liver cancer	0.000335	0.000828	CcSEcCtD
Fentanyl—Infestation—Epirubicin—liver cancer	0.000333	0.000824	CcSEcCtD
Fentanyl—Drowsiness—Epirubicin—liver cancer	0.000333	0.000824	CcSEcCtD
Fentanyl—Infestation NOS—Epirubicin—liver cancer	0.000333	0.000824	CcSEcCtD
Fentanyl—Bronchitis—Doxorubicin—liver cancer	0.000332	0.000822	CcSEcCtD
Fentanyl—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00033	0.000817	CcSEcCtD
Fentanyl—Pancytopenia—Doxorubicin—liver cancer	0.000328	0.000812	CcSEcCtD
Fentanyl—Renal failure—Epirubicin—liver cancer	0.000327	0.00081	CcSEcCtD
Fentanyl—Neuropathy peripheral—Epirubicin—liver cancer	0.000326	0.000807	CcSEcCtD
Fentanyl—Stomatitis—Epirubicin—liver cancer	0.000325	0.000803	CcSEcCtD
Fentanyl—Jaundice—Epirubicin—liver cancer	0.000325	0.000803	CcSEcCtD
Fentanyl—Conjunctivitis—Epirubicin—liver cancer	0.000324	0.000801	CcSEcCtD
Fentanyl—Urinary tract infection—Epirubicin—liver cancer	0.000324	0.000801	CcSEcCtD
Fentanyl—Neutropenia—Doxorubicin—liver cancer	0.000323	0.000799	CcSEcCtD
Fentanyl—Dysuria—Doxorubicin—liver cancer	0.000323	0.000799	CcSEcCtD
Fentanyl—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000321	0.000794	CcSEcCtD
Fentanyl—Sweating—Epirubicin—liver cancer	0.000319	0.00079	CcSEcCtD
Fentanyl—Pollakiuria—Doxorubicin—liver cancer	0.000319	0.00079	CcSEcCtD
Fentanyl—Haematuria—Epirubicin—liver cancer	0.000318	0.000785	CcSEcCtD
Fentanyl—Hepatobiliary disease—Epirubicin—liver cancer	0.000315	0.000779	CcSEcCtD
Fentanyl—Weight increased—Doxorubicin—liver cancer	0.000315	0.000778	CcSEcCtD
Fentanyl—Epistaxis—Epirubicin—liver cancer	0.000314	0.000777	CcSEcCtD
Fentanyl—Weight decreased—Doxorubicin—liver cancer	0.000313	0.000773	CcSEcCtD
Fentanyl—Sinusitis—Epirubicin—liver cancer	0.000312	0.000773	CcSEcCtD
Fentanyl—Hyperglycaemia—Doxorubicin—liver cancer	0.000312	0.000771	CcSEcCtD
Fentanyl—Pneumonia—Doxorubicin—liver cancer	0.00031	0.000766	CcSEcCtD
Fentanyl—Infestation—Doxorubicin—liver cancer	0.000308	0.000762	CcSEcCtD
Fentanyl—Infestation NOS—Doxorubicin—liver cancer	0.000308	0.000762	CcSEcCtD
Fentanyl—Drowsiness—Doxorubicin—liver cancer	0.000308	0.000762	CcSEcCtD
Fentanyl—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000305	0.000756	CcSEcCtD
Fentanyl—Bradycardia—Epirubicin—liver cancer	0.000304	0.000753	CcSEcCtD
Fentanyl—Renal failure—Doxorubicin—liver cancer	0.000303	0.000749	CcSEcCtD
Fentanyl—Neuropathy peripheral—Doxorubicin—liver cancer	0.000302	0.000747	CcSEcCtD
Fentanyl—Haemoglobin—Epirubicin—liver cancer	0.0003	0.000743	CcSEcCtD
Fentanyl—Stomatitis—Doxorubicin—liver cancer	0.0003	0.000743	CcSEcCtD
Fentanyl—Jaundice—Doxorubicin—liver cancer	0.0003	0.000743	CcSEcCtD
Fentanyl—Rhinitis—Epirubicin—liver cancer	0.0003	0.000741	CcSEcCtD
Fentanyl—Conjunctivitis—Doxorubicin—liver cancer	0.0003	0.000741	CcSEcCtD
Fentanyl—Urinary tract infection—Doxorubicin—liver cancer	0.0003	0.000741	CcSEcCtD
Fentanyl—Haemorrhage—Epirubicin—liver cancer	0.000299	0.000739	CcSEcCtD
Fentanyl—Hypoaesthesia—Epirubicin—liver cancer	0.000297	0.000736	CcSEcCtD
Fentanyl—Pharyngitis—Epirubicin—liver cancer	0.000297	0.000734	CcSEcCtD
Fentanyl—Sweating—Doxorubicin—liver cancer	0.000295	0.000731	CcSEcCtD
Fentanyl—Urinary tract disorder—Epirubicin—liver cancer	0.000295	0.00073	CcSEcCtD
Fentanyl—Oedema peripheral—Epirubicin—liver cancer	0.000294	0.000728	CcSEcCtD
Fentanyl—Haematuria—Doxorubicin—liver cancer	0.000294	0.000727	CcSEcCtD
Fentanyl—Connective tissue disorder—Epirubicin—liver cancer	0.000294	0.000727	CcSEcCtD
Fentanyl—Urethral disorder—Epirubicin—liver cancer	0.000293	0.000725	CcSEcCtD
Fentanyl—Hepatobiliary disease—Doxorubicin—liver cancer	0.000291	0.000721	CcSEcCtD
Fentanyl—Epistaxis—Doxorubicin—liver cancer	0.000291	0.000719	CcSEcCtD
Fentanyl—Sinusitis—Doxorubicin—liver cancer	0.000289	0.000715	CcSEcCtD
Fentanyl—Visual impairment—Epirubicin—liver cancer	0.000288	0.000712	CcSEcCtD
Fentanyl—Erythema multiforme—Epirubicin—liver cancer	0.000283	0.000699	CcSEcCtD
Fentanyl—Bradycardia—Doxorubicin—liver cancer	0.000282	0.000696	CcSEcCtD
Fentanyl—Eye disorder—Epirubicin—liver cancer	0.000279	0.000691	CcSEcCtD
Fentanyl—Tinnitus—Epirubicin—liver cancer	0.000279	0.000689	CcSEcCtD
Fentanyl—Haemoglobin—Doxorubicin—liver cancer	0.000278	0.000688	CcSEcCtD
Fentanyl—Cardiac disorder—Epirubicin—liver cancer	0.000277	0.000686	CcSEcCtD
Fentanyl—Flushing—Epirubicin—liver cancer	0.000277	0.000686	CcSEcCtD
Fentanyl—Rhinitis—Doxorubicin—liver cancer	0.000277	0.000686	CcSEcCtD
Fentanyl—Haemorrhage—Doxorubicin—liver cancer	0.000277	0.000684	CcSEcCtD
Fentanyl—Hypoaesthesia—Doxorubicin—liver cancer	0.000275	0.000681	CcSEcCtD
Fentanyl—Pharyngitis—Doxorubicin—liver cancer	0.000275	0.000679	CcSEcCtD
Fentanyl—Urinary tract disorder—Doxorubicin—liver cancer	0.000273	0.000676	CcSEcCtD
Fentanyl—Oedema peripheral—Doxorubicin—liver cancer	0.000272	0.000674	CcSEcCtD
Fentanyl—Connective tissue disorder—Doxorubicin—liver cancer	0.000272	0.000672	CcSEcCtD
Fentanyl—Angiopathy—Epirubicin—liver cancer	0.000271	0.000671	CcSEcCtD
Fentanyl—Urethral disorder—Doxorubicin—liver cancer	0.000271	0.000671	CcSEcCtD
Fentanyl—Immune system disorder—Epirubicin—liver cancer	0.00027	0.000668	CcSEcCtD
Fentanyl—Mediastinal disorder—Epirubicin—liver cancer	0.000269	0.000666	CcSEcCtD
Fentanyl—Chills—Epirubicin—liver cancer	0.000268	0.000663	CcSEcCtD
Fentanyl—Arrhythmia—Epirubicin—liver cancer	0.000267	0.00066	CcSEcCtD
Fentanyl—Visual impairment—Doxorubicin—liver cancer	0.000267	0.000659	CcSEcCtD
Fentanyl—Alopecia—Epirubicin—liver cancer	0.000264	0.000653	CcSEcCtD
Fentanyl—Mental disorder—Epirubicin—liver cancer	0.000262	0.000648	CcSEcCtD
Fentanyl—Erythema multiforme—Doxorubicin—liver cancer	0.000262	0.000647	CcSEcCtD
Fentanyl—Erythema—Epirubicin—liver cancer	0.00026	0.000644	CcSEcCtD
Fentanyl—Malnutrition—Epirubicin—liver cancer	0.00026	0.000644	CcSEcCtD
Fentanyl—Eye disorder—Doxorubicin—liver cancer	0.000258	0.000639	CcSEcCtD
Fentanyl—Tinnitus—Doxorubicin—liver cancer	0.000258	0.000638	CcSEcCtD
Fentanyl—Cardiac disorder—Doxorubicin—liver cancer	0.000257	0.000635	CcSEcCtD
Fentanyl—Flushing—Doxorubicin—liver cancer	0.000257	0.000635	CcSEcCtD
Fentanyl—Flatulence—Epirubicin—liver cancer	0.000256	0.000634	CcSEcCtD
Fentanyl—Tension—Epirubicin—liver cancer	0.000255	0.000632	CcSEcCtD
Fentanyl—Dysgeusia—Epirubicin—liver cancer	0.000255	0.00063	CcSEcCtD
Fentanyl—Nervousness—Epirubicin—liver cancer	0.000253	0.000625	CcSEcCtD
Fentanyl—Back pain—Epirubicin—liver cancer	0.000252	0.000623	CcSEcCtD
Fentanyl—Angiopathy—Doxorubicin—liver cancer	0.000251	0.000621	CcSEcCtD
Fentanyl—Muscle spasms—Epirubicin—liver cancer	0.00025	0.000619	CcSEcCtD
Fentanyl—Immune system disorder—Doxorubicin—liver cancer	0.00025	0.000618	CcSEcCtD
Fentanyl—Mediastinal disorder—Doxorubicin—liver cancer	0.000249	0.000617	CcSEcCtD
Fentanyl—Chills—Doxorubicin—liver cancer	0.000248	0.000614	CcSEcCtD
Fentanyl—Arrhythmia—Doxorubicin—liver cancer	0.000247	0.000611	CcSEcCtD
Fentanyl—Vision blurred—Epirubicin—liver cancer	0.000245	0.000607	CcSEcCtD
Fentanyl—Alopecia—Doxorubicin—liver cancer	0.000244	0.000605	CcSEcCtD
Fentanyl—Mental disorder—Doxorubicin—liver cancer	0.000242	0.000599	CcSEcCtD
Fentanyl—Ill-defined disorder—Epirubicin—liver cancer	0.000241	0.000597	CcSEcCtD
Fentanyl—Erythema—Doxorubicin—liver cancer	0.000241	0.000596	CcSEcCtD
Fentanyl—Malnutrition—Doxorubicin—liver cancer	0.000241	0.000596	CcSEcCtD
Fentanyl—Anaemia—Epirubicin—liver cancer	0.000241	0.000595	CcSEcCtD
Fentanyl—Agitation—Epirubicin—liver cancer	0.000239	0.000591	CcSEcCtD
Fentanyl—Flatulence—Doxorubicin—liver cancer	0.000237	0.000587	CcSEcCtD
Fentanyl—Tension—Doxorubicin—liver cancer	0.000236	0.000584	CcSEcCtD
Fentanyl—Dysgeusia—Doxorubicin—liver cancer	0.000236	0.000583	CcSEcCtD
Fentanyl—Malaise—Epirubicin—liver cancer	0.000235	0.00058	CcSEcCtD
Fentanyl—Nervousness—Doxorubicin—liver cancer	0.000234	0.000578	CcSEcCtD
Fentanyl—Vertigo—Epirubicin—liver cancer	0.000234	0.000578	CcSEcCtD
Fentanyl—Syncope—Epirubicin—liver cancer	0.000233	0.000577	CcSEcCtD
Fentanyl—Leukopenia—Epirubicin—liver cancer	0.000233	0.000576	CcSEcCtD
Fentanyl—Back pain—Doxorubicin—liver cancer	0.000233	0.000576	CcSEcCtD
Fentanyl—Muscle spasms—Doxorubicin—liver cancer	0.000232	0.000573	CcSEcCtD
Fentanyl—Palpitations—Epirubicin—liver cancer	0.00023	0.000569	CcSEcCtD
Fentanyl—Loss of consciousness—Epirubicin—liver cancer	0.000229	0.000566	CcSEcCtD
Fentanyl—Cough—Epirubicin—liver cancer	0.000227	0.000562	CcSEcCtD
Fentanyl—Vision blurred—Doxorubicin—liver cancer	0.000227	0.000561	CcSEcCtD
Fentanyl—Convulsion—Epirubicin—liver cancer	0.000225	0.000558	CcSEcCtD
Fentanyl—Hypertension—Epirubicin—liver cancer	0.000225	0.000556	CcSEcCtD
Fentanyl—Ill-defined disorder—Doxorubicin—liver cancer	0.000223	0.000553	CcSEcCtD
Fentanyl—Anaemia—Doxorubicin—liver cancer	0.000223	0.00055	CcSEcCtD
Fentanyl—Arthralgia—Epirubicin—liver cancer	0.000222	0.000548	CcSEcCtD
Fentanyl—Myalgia—Epirubicin—liver cancer	0.000222	0.000548	CcSEcCtD
Fentanyl—Chest pain—Epirubicin—liver cancer	0.000222	0.000548	CcSEcCtD
Fentanyl—Agitation—Doxorubicin—liver cancer	0.000221	0.000547	CcSEcCtD
Fentanyl—Anxiety—Epirubicin—liver cancer	0.000221	0.000546	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00022	0.000544	CcSEcCtD
Fentanyl—Discomfort—Epirubicin—liver cancer	0.000219	0.000541	CcSEcCtD
Fentanyl—Malaise—Doxorubicin—liver cancer	0.000217	0.000537	CcSEcCtD
Fentanyl—Dry mouth—Epirubicin—liver cancer	0.000217	0.000536	CcSEcCtD
Fentanyl—Vertigo—Doxorubicin—liver cancer	0.000216	0.000535	CcSEcCtD
Fentanyl—Syncope—Doxorubicin—liver cancer	0.000216	0.000534	CcSEcCtD
Fentanyl—Leukopenia—Doxorubicin—liver cancer	0.000216	0.000533	CcSEcCtD
Fentanyl—Confusional state—Epirubicin—liver cancer	0.000214	0.00053	CcSEcCtD
Fentanyl—Palpitations—Doxorubicin—liver cancer	0.000213	0.000526	CcSEcCtD
Fentanyl—Oedema—Epirubicin—liver cancer	0.000212	0.000525	CcSEcCtD
Fentanyl—Anaphylactic shock—Epirubicin—liver cancer	0.000212	0.000525	CcSEcCtD
Fentanyl—Loss of consciousness—Doxorubicin—liver cancer	0.000212	0.000523	CcSEcCtD
Fentanyl—Infection—Epirubicin—liver cancer	0.000211	0.000522	CcSEcCtD
Fentanyl—Cough—Doxorubicin—liver cancer	0.00021	0.00052	CcSEcCtD
Fentanyl—Shock—Epirubicin—liver cancer	0.000209	0.000517	CcSEcCtD
Fentanyl—Convulsion—Doxorubicin—liver cancer	0.000209	0.000516	CcSEcCtD
Fentanyl—Nervous system disorder—Epirubicin—liver cancer	0.000208	0.000515	CcSEcCtD
Fentanyl—Thrombocytopenia—Epirubicin—liver cancer	0.000208	0.000514	CcSEcCtD
Fentanyl—Hypertension—Doxorubicin—liver cancer	0.000208	0.000514	CcSEcCtD
Fentanyl—Tachycardia—Epirubicin—liver cancer	0.000207	0.000513	CcSEcCtD
Fentanyl—Skin disorder—Epirubicin—liver cancer	0.000206	0.00051	CcSEcCtD
Fentanyl—Hyperhidrosis—Epirubicin—liver cancer	0.000205	0.000508	CcSEcCtD
Fentanyl—Arthralgia—Doxorubicin—liver cancer	0.000205	0.000507	CcSEcCtD
Fentanyl—Myalgia—Doxorubicin—liver cancer	0.000205	0.000507	CcSEcCtD
Fentanyl—Chest pain—Doxorubicin—liver cancer	0.000205	0.000507	CcSEcCtD
Fentanyl—Anxiety—Doxorubicin—liver cancer	0.000204	0.000505	CcSEcCtD
Fentanyl—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000204	0.000504	CcSEcCtD
Fentanyl—Discomfort—Doxorubicin—liver cancer	0.000203	0.000501	CcSEcCtD
Fentanyl—Anorexia—Epirubicin—liver cancer	0.000202	0.000501	CcSEcCtD
Fentanyl—Dry mouth—Doxorubicin—liver cancer	0.0002	0.000496	CcSEcCtD
Fentanyl—Hypotension—Epirubicin—liver cancer	0.000198	0.000491	CcSEcCtD
Fentanyl—Confusional state—Doxorubicin—liver cancer	0.000198	0.00049	CcSEcCtD
Fentanyl—Oedema—Doxorubicin—liver cancer	0.000197	0.000486	CcSEcCtD
Fentanyl—Anaphylactic shock—Doxorubicin—liver cancer	0.000197	0.000486	CcSEcCtD
Fentanyl—Infection—Doxorubicin—liver cancer	0.000195	0.000483	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000194	0.000479	CcSEcCtD
Fentanyl—Shock—Doxorubicin—liver cancer	0.000193	0.000478	CcSEcCtD
Fentanyl—Nervous system disorder—Doxorubicin—liver cancer	0.000193	0.000477	CcSEcCtD
Fentanyl—Thrombocytopenia—Doxorubicin—liver cancer	0.000192	0.000476	CcSEcCtD
Fentanyl—Insomnia—Epirubicin—liver cancer	0.000192	0.000475	CcSEcCtD
Fentanyl—Tachycardia—Doxorubicin—liver cancer	0.000192	0.000474	CcSEcCtD
Fentanyl—Skin disorder—Doxorubicin—liver cancer	0.000191	0.000472	CcSEcCtD
Fentanyl—Paraesthesia—Epirubicin—liver cancer	0.000191	0.000472	CcSEcCtD
Fentanyl—Hyperhidrosis—Doxorubicin—liver cancer	0.00019	0.00047	CcSEcCtD
Fentanyl—Dyspnoea—Epirubicin—liver cancer	0.000189	0.000468	CcSEcCtD
Fentanyl—Somnolence—Epirubicin—liver cancer	0.000189	0.000467	CcSEcCtD
Fentanyl—Anorexia—Doxorubicin—liver cancer	0.000187	0.000463	CcSEcCtD
Fentanyl—Dyspepsia—Epirubicin—liver cancer	0.000187	0.000462	CcSEcCtD
Fentanyl—Decreased appetite—Epirubicin—liver cancer	0.000185	0.000457	CcSEcCtD
Fentanyl—Alfentanil—ALB—liver cancer	0.000184	0.336	CrCbGaD
Fentanyl—Hypotension—Doxorubicin—liver cancer	0.000184	0.000454	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Epirubicin—liver cancer	0.000183	0.000453	CcSEcCtD
Fentanyl—Fatigue—Epirubicin—liver cancer	0.000183	0.000453	CcSEcCtD
Fentanyl—Pain—Epirubicin—liver cancer	0.000182	0.000449	CcSEcCtD
Fentanyl—Constipation—Epirubicin—liver cancer	0.000182	0.000449	CcSEcCtD
Fentanyl—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000179	0.000443	CcSEcCtD
Fentanyl—Insomnia—Doxorubicin—liver cancer	0.000178	0.00044	CcSEcCtD
Fentanyl—Paraesthesia—Doxorubicin—liver cancer	0.000176	0.000436	CcSEcCtD
Fentanyl—Dyspnoea—Doxorubicin—liver cancer	0.000175	0.000433	CcSEcCtD
Fentanyl—Feeling abnormal—Epirubicin—liver cancer	0.000175	0.000433	CcSEcCtD
Fentanyl—Somnolence—Doxorubicin—liver cancer	0.000175	0.000432	CcSEcCtD
Fentanyl—Gastrointestinal pain—Epirubicin—liver cancer	0.000174	0.00043	CcSEcCtD
Fentanyl—Dyspepsia—Doxorubicin—liver cancer	0.000173	0.000428	CcSEcCtD
Fentanyl—Decreased appetite—Doxorubicin—liver cancer	0.000171	0.000422	CcSEcCtD
Fentanyl—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00017	0.00042	CcSEcCtD
Fentanyl—Fatigue—Doxorubicin—liver cancer	0.000169	0.000419	CcSEcCtD
Fentanyl—Urticaria—Epirubicin—liver cancer	0.000169	0.000417	CcSEcCtD
Fentanyl—Pain—Doxorubicin—liver cancer	0.000168	0.000416	CcSEcCtD
Fentanyl—Constipation—Doxorubicin—liver cancer	0.000168	0.000416	CcSEcCtD
Fentanyl—Abdominal pain—Epirubicin—liver cancer	0.000168	0.000415	CcSEcCtD
Fentanyl—Body temperature increased—Epirubicin—liver cancer	0.000168	0.000415	CcSEcCtD
Fentanyl—Feeling abnormal—Doxorubicin—liver cancer	0.000162	0.000401	CcSEcCtD
Fentanyl—Gastrointestinal pain—Doxorubicin—liver cancer	0.000161	0.000397	CcSEcCtD
Fentanyl—Hypersensitivity—Epirubicin—liver cancer	0.000156	0.000387	CcSEcCtD
Fentanyl—Urticaria—Doxorubicin—liver cancer	0.000156	0.000386	CcSEcCtD
Fentanyl—Abdominal pain—Doxorubicin—liver cancer	0.000155	0.000384	CcSEcCtD
Fentanyl—Body temperature increased—Doxorubicin—liver cancer	0.000155	0.000384	CcSEcCtD
Fentanyl—Asthenia—Epirubicin—liver cancer	0.000152	0.000377	CcSEcCtD
Fentanyl—Pruritus—Epirubicin—liver cancer	0.00015	0.000372	CcSEcCtD
Fentanyl—Diarrhoea—Epirubicin—liver cancer	0.000145	0.000359	CcSEcCtD
Fentanyl—Hypersensitivity—Doxorubicin—liver cancer	0.000145	0.000358	CcSEcCtD
Fentanyl—Asthenia—Doxorubicin—liver cancer	0.000141	0.000349	CcSEcCtD
Fentanyl—Dizziness—Epirubicin—liver cancer	0.00014	0.000347	CcSEcCtD
Fentanyl—Pruritus—Doxorubicin—liver cancer	0.000139	0.000344	CcSEcCtD
Fentanyl—Vomiting—Epirubicin—liver cancer	0.000135	0.000334	CcSEcCtD
Fentanyl—Diarrhoea—Doxorubicin—liver cancer	0.000134	0.000333	CcSEcCtD
Fentanyl—Rash—Epirubicin—liver cancer	0.000134	0.000331	CcSEcCtD
Fentanyl—Dermatitis—Epirubicin—liver cancer	0.000134	0.000331	CcSEcCtD
Fentanyl—Headache—Epirubicin—liver cancer	0.000133	0.000329	CcSEcCtD
Fentanyl—Dizziness—Doxorubicin—liver cancer	0.00013	0.000321	CcSEcCtD
Fentanyl—Nausea—Epirubicin—liver cancer	0.000126	0.000312	CcSEcCtD
Fentanyl—Vomiting—Doxorubicin—liver cancer	0.000125	0.000309	CcSEcCtD
Fentanyl—Rash—Doxorubicin—liver cancer	0.000124	0.000306	CcSEcCtD
Fentanyl—Dermatitis—Doxorubicin—liver cancer	0.000124	0.000306	CcSEcCtD
Fentanyl—Headache—Doxorubicin—liver cancer	0.000123	0.000304	CcSEcCtD
Fentanyl—Nausea—Doxorubicin—liver cancer	0.000117	0.000289	CcSEcCtD
Fentanyl—OPRD1—Signaling Pathways—H2AFX—liver cancer	2.82e-05	0.000448	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—IL2—liver cancer	2.82e-05	0.000448	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—F2—liver cancer	2.82e-05	0.000448	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—PIK3CD—liver cancer	2.8e-05	0.000446	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—PIK3CB—liver cancer	2.79e-05	0.000443	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	2.76e-05	0.000438	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—TAT—liver cancer	2.74e-05	0.000435	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CYCS—liver cancer	2.72e-05	0.000433	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PIK3CG—liver cancer	2.7e-05	0.000429	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—PIK3CB—liver cancer	2.69e-05	0.000428	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IGF2—liver cancer	2.69e-05	0.000427	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GGT1—liver cancer	2.67e-05	0.000425	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GOT1—liver cancer	2.67e-05	0.000425	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	2.64e-05	0.00042	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	2.64e-05	0.000419	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTA4—liver cancer	2.62e-05	0.000417	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—PIK3CD—liver cancer	2.61e-05	0.000415	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—HPGDS—liver cancer	2.58e-05	0.00041	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL2—liver cancer	2.56e-05	0.000407	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTA2—liver cancer	2.55e-05	0.000406	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TERT—liver cancer	2.55e-05	0.000405	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CSF2—liver cancer	2.51e-05	0.000399	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—RAF1—liver cancer	2.5e-05	0.000398	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—H2AFX—liver cancer	2.47e-05	0.000393	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—IL2—liver cancer	2.47e-05	0.000393	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTA1—liver cancer	2.46e-05	0.000392	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	2.46e-05	0.000391	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—PIK3CB—liver cancer	2.44e-05	0.000389	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	2.44e-05	0.000388	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—NAT2—liver cancer	2.44e-05	0.000387	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GSTP1—liver cancer	2.4e-05	0.000382	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PRKCE—liver cancer	2.4e-05	0.000381	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PIK3CD—liver cancer	2.37e-05	0.000377	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—HMOX1—liver cancer	2.37e-05	0.000376	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ALDOB—liver cancer	2.34e-05	0.000371	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—KDR—liver cancer	2.33e-05	0.000371	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MAPK14—liver cancer	2.32e-05	0.000368	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PSMA4—liver cancer	2.3e-05	0.000366	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PSMD10—liver cancer	2.3e-05	0.000366	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—PIK3CB—liver cancer	2.27e-05	0.000362	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—ESR1—liver cancer	2.27e-05	0.000361	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IGF2—liver cancer	2.27e-05	0.000361	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—F2—liver cancer	2.24e-05	0.000357	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL2—liver cancer	2.24e-05	0.000357	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	2.24e-05	0.000357	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GOT2—liver cancer	2.24e-05	0.000356	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TERT—liver cancer	2.24e-05	0.000356	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CRABP1—liver cancer	2.23e-05	0.000354	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	2.23e-05	0.000354	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—GSTM1—liver cancer	2.21e-05	0.000351	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	2.17e-05	0.000345	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—APC—liver cancer	2.15e-05	0.000342	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CG—liver cancer	2.15e-05	0.000342	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CSF2—liver cancer	2.12e-05	0.000337	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—RAF1—liver cancer	2.12e-05	0.000336	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP2E1—liver cancer	2.1e-05	0.000334	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—CYP1A1—liver cancer	2.09e-05	0.000332	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—H2AFX—liver cancer	2.09e-05	0.000332	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—IL2—liver cancer	2.09e-05	0.000332	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PIK3CB—liver cancer	2.07e-05	0.000328	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—KDR—liver cancer	2.05e-05	0.000325	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MAPK14—liver cancer	2.03e-05	0.000323	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—BRAF—liver cancer	2.02e-05	0.000321	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—ESR1—liver cancer	1.99e-05	0.000317	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—F2—liver cancer	1.97e-05	0.000313	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYCS—liver cancer	1.97e-05	0.000313	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—MTHFR—liver cancer	1.95e-05	0.00031	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—HPGDS—liver cancer	1.95e-05	0.00031	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GGT1—liver cancer	1.93e-05	0.000307	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GOT1—liver cancer	1.93e-05	0.000307	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PPARA—liver cancer	1.91e-05	0.000304	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL2—liver cancer	1.9e-05	0.000302	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TERT—liver cancer	1.89e-05	0.0003	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CD—liver cancer	1.89e-05	0.0003	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CG—liver cancer	1.88e-05	0.0003	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—APC—liver cancer	1.88e-05	0.0003	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—PIK3CA—liver cancer	1.87e-05	0.000297	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—SERPINE1—liver cancer	1.87e-05	0.000297	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CPT1B—liver cancer	1.86e-05	0.000296	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GLUL—liver cancer	1.86e-05	0.000296	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—KRAS—liver cancer	1.85e-05	0.000294	CbGpPWpGaD
Fentanyl—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	1.83e-05	0.000291	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NR1H4—liver cancer	1.8e-05	0.000285	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—BRAF—liver cancer	1.77e-05	0.000282	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTA3—liver cancer	1.76e-05	0.000281	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PSMA4—liver cancer	1.74e-05	0.000276	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PSMD10—liver cancer	1.74e-05	0.000276	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GSTP1—liver cancer	1.73e-05	0.000276	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KDR—liver cancer	1.73e-05	0.000275	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MAPK14—liver cancer	1.72e-05	0.000273	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—HMOX1—liver cancer	1.71e-05	0.000272	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—PIK3CA—liver cancer	1.7e-05	0.00027	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GOT2—liver cancer	1.69e-05	0.000268	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—RAF1—liver cancer	1.69e-05	0.000268	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—ESR1—liver cancer	1.68e-05	0.000268	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—F2—liver cancer	1.66e-05	0.000265	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CD—liver cancer	1.66e-05	0.000263	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	1.66e-05	0.000263	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MTOR—liver cancer	1.65e-05	0.000262	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CB—liver cancer	1.65e-05	0.000262	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—PIK3CA—liver cancer	1.64e-05	0.000261	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—SERPINE1—liver cancer	1.64e-05	0.00026	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CG—liver cancer	1.64e-05	0.00026	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—KRAS—liver cancer	1.62e-05	0.000258	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTA4—liver cancer	1.61e-05	0.000257	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—GSTM1—liver cancer	1.59e-05	0.000253	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CG—liver cancer	1.59e-05	0.000253	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—APC—liver cancer	1.59e-05	0.000253	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP2E1—liver cancer	1.59e-05	0.000252	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PPARG—liver cancer	1.58e-05	0.000251	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTA2—liver cancer	1.57e-05	0.00025	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—HRAS—liver cancer	1.57e-05	0.00025	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CDKN1B—liver cancer	1.54e-05	0.000246	CbGpPWpGaD
Fentanyl—OPRD1—GPCR downstream signaling—AKT1—liver cancer	1.53e-05	0.000243	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTA1—liver cancer	1.52e-05	0.000241	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CASP3—liver cancer	1.51e-05	0.000241	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL2—liver cancer	1.51e-05	0.00024	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—CYP1A1—liver cancer	1.51e-05	0.00024	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—IL6—liver cancer	1.5e-05	0.000239	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—NAT2—liver cancer	1.5e-05	0.000239	CbGpPWpGaD
Fentanyl—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.5e-05	0.000238	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—BRAF—liver cancer	1.5e-05	0.000238	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—PIK3CA—liver cancer	1.49e-05	0.000237	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYCS—liver cancer	1.49e-05	0.000236	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—RAF1—liver cancer	1.48e-05	0.000235	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CCND1—liver cancer	1.47e-05	0.000234	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—JUN—liver cancer	1.47e-05	0.000234	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CTNNB1—liver cancer	1.46e-05	0.000232	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GOT1—liver cancer	1.46e-05	0.000232	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GGT1—liver cancer	1.46e-05	0.000232	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CB—liver cancer	1.44e-05	0.00023	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MTOR—liver cancer	1.44e-05	0.00023	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CD—liver cancer	1.44e-05	0.000229	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALDOB—liver cancer	1.44e-05	0.000229	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MMP9—liver cancer	1.43e-05	0.000227	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—CDKN1A—liver cancer	1.43e-05	0.000227	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—ALB—liver cancer	1.42e-05	0.000226	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—MTHFR—liver cancer	1.41e-05	0.000224	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CD—liver cancer	1.4e-05	0.000223	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MAPK8—liver cancer	1.39e-05	0.000221	CbGpPWpGaD
Fentanyl—OPRD1—Signaling by GPCR—AKT1—liver cancer	1.39e-05	0.000221	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—PIK3CA—liver cancer	1.39e-05	0.00022	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—SERPINE1—liver cancer	1.38e-05	0.00022	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PPARA—liver cancer	1.38e-05	0.00022	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—HRAS—liver cancer	1.38e-05	0.000219	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CRABP1—liver cancer	1.37e-05	0.000218	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—KRAS—liver cancer	1.37e-05	0.000218	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CDKN1B—liver cancer	1.35e-05	0.000215	CbGpPWpGaD
Fentanyl—OPRK1—GPCR downstream signaling—AKT1—liver cancer	1.34e-05	0.000213	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CASP3—liver cancer	1.33e-05	0.000211	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL2—liver cancer	1.33e-05	0.000211	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—IL6—liver cancer	1.32e-05	0.00021	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTP1—liver cancer	1.31e-05	0.000208	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CCND1—liver cancer	1.29e-05	0.000205	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—HMOX1—liver cancer	1.29e-05	0.000205	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—JUN—liver cancer	1.29e-05	0.000205	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—VEGFA—liver cancer	1.28e-05	0.000204	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CTNNB1—liver cancer	1.28e-05	0.000203	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—STAT3—liver cancer	1.27e-05	0.000202	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—PIK3CA—liver cancer	1.26e-05	0.0002	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CB—liver cancer	1.25e-05	0.0002	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MMP9—liver cancer	1.25e-05	0.000199	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—CDKN1A—liver cancer	1.25e-05	0.000199	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—RAF1—liver cancer	1.25e-05	0.000199	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MAPK8—liver cancer	1.22e-05	0.000194	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MTOR—liver cancer	1.22e-05	0.000194	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CB—liver cancer	1.22e-05	0.000194	CbGpPWpGaD
Fentanyl—OPRK1—Signaling by GPCR—AKT1—liver cancer	1.22e-05	0.000193	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—GSTM1—liver cancer	1.2e-05	0.000191	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HPGDS—liver cancer	1.2e-05	0.000191	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CG—liver cancer	1.18e-05	0.000188	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—MYC—liver cancer	1.18e-05	0.000188	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TGFB1—liver cancer	1.18e-05	0.000187	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—HRAS—liver cancer	1.16e-05	0.000185	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CDKN1B—liver cancer	1.14e-05	0.000182	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PPARG—liver cancer	1.14e-05	0.000182	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—CYP1A1—liver cancer	1.14e-05	0.000181	CbGpPWpGaD
Fentanyl—OPRM1—GPCR downstream signaling—AKT1—liver cancer	1.13e-05	0.00018	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—VEGFA—liver cancer	1.13e-05	0.000179	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CASP3—liver cancer	1.12e-05	0.000178	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL2—liver cancer	1.12e-05	0.000178	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—STAT3—liver cancer	1.12e-05	0.000177	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—IL6—liver cancer	1.11e-05	0.000177	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—KRAS—liver cancer	1.09e-05	0.000174	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CCND1—liver cancer	1.09e-05	0.000174	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—JUN—liver cancer	1.09e-05	0.000173	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CTNNB1—liver cancer	1.08e-05	0.000172	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PSMA4—liver cancer	1.07e-05	0.00017	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PSMD10—liver cancer	1.07e-05	0.00017	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—MTHFR—liver cancer	1.06e-05	0.000169	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MMP9—liver cancer	1.06e-05	0.000169	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—CDKN1A—liver cancer	1.06e-05	0.000168	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PPARA—liver cancer	1.04e-05	0.000166	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CD—liver cancer	1.04e-05	0.000165	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GOT2—liver cancer	1.04e-05	0.000165	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—MYC—liver cancer	1.04e-05	0.000165	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TGFB1—liver cancer	1.03e-05	0.000164	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MAPK8—liver cancer	1.03e-05	0.000164	CbGpPWpGaD
Fentanyl—OPRM1—Signaling by GPCR—AKT1—liver cancer	1.03e-05	0.000164	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—ALB—liver cancer	1.03e-05	0.000163	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—PIK3CA—liver cancer	1e-05	0.00016	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP2E1—liver cancer	9.78e-06	0.000155	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—TP53—liver cancer	9.71e-06	0.000154	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—KRAS—liver cancer	9.58e-06	0.000152	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—VEGFA—liver cancer	9.52e-06	0.000151	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—STAT3—liver cancer	9.43e-06	0.00015	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—HRAS—liver cancer	9.28e-06	0.000148	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYCS—liver cancer	9.15e-06	0.000145	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CB—liver cancer	9.07e-06	0.000144	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GOT1—liver cancer	8.98e-06	0.000143	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GGT1—liver cancer	8.98e-06	0.000143	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CG—liver cancer	8.93e-06	0.000142	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—IL6—liver cancer	8.89e-06	0.000141	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—PIK3CA—liver cancer	8.8e-06	0.00014	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—MYC—liver cancer	8.76e-06	0.000139	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TGFB1—liver cancer	8.74e-06	0.000139	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PPARG—liver cancer	8.62e-06	0.000137	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—TP53—liver cancer	8.51e-06	0.000135	CbGpPWpGaD
Fentanyl—OPRD1—Signaling Pathways—AKT1—liver cancer	8.2e-06	0.00013	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—HRAS—liver cancer	8.14e-06	0.000129	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—KRAS—liver cancer	8.1e-06	0.000129	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTP1—liver cancer	8.07e-06	0.000128	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—HMOX1—liver cancer	7.95e-06	0.000126	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CD—liver cancer	7.85e-06	0.000125	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—IL6—liver cancer	7.79e-06	0.000124	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—ALB—liver cancer	7.75e-06	0.000123	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—PIK3CA—liver cancer	7.65e-06	0.000122	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—PIK3CA—liver cancer	7.44e-06	0.000118	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—GSTM1—liver cancer	7.41e-06	0.000118	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—TP53—liver cancer	7.19e-06	0.000114	CbGpPWpGaD
Fentanyl—OPRK1—Signaling Pathways—AKT1—liver cancer	7.19e-06	0.000114	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—CYP1A1—liver cancer	7.03e-06	0.000112	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—HRAS—liver cancer	6.88e-06	0.000109	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CB—liver cancer	6.84e-06	0.000109	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—IL6—liver cancer	6.59e-06	0.000105	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—MTHFR—liver cancer	6.55e-06	0.000104	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPARA—liver cancer	6.43e-06	0.000102	CbGpPWpGaD
Fentanyl—CYP3A7—Metabolism—AKT1—liver cancer	6.25e-06	9.94e-05	CbGpPWpGaD
Fentanyl—OPRM1—Signaling Pathways—AKT1—liver cancer	6.08e-06	9.66e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—PIK3CA—liver cancer	5.53e-06	8.79e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CG—liver cancer	5.5e-06	8.75e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PPARG—liver cancer	5.31e-06	8.45e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CD—liver cancer	4.84e-06	7.69e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—ALB—liver cancer	4.78e-06	7.59e-05	CbGpPWpGaD
Fentanyl—CYP3A5—Metabolism—AKT1—liver cancer	4.52e-06	7.18e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CB—liver cancer	4.22e-06	6.7e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—PIK3CA—liver cancer	4.17e-06	6.63e-05	CbGpPWpGaD
Fentanyl—ABCB1—Metabolism—AKT1—liver cancer	3.41e-06	5.42e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—PIK3CA—liver cancer	2.57e-06	4.09e-05	CbGpPWpGaD
Fentanyl—CYP3A4—Metabolism—AKT1—liver cancer	2.1e-06	3.34e-05	CbGpPWpGaD
